Axa china biotech services sign mou to explore cancer treatment option for policyholders rein asia

Emerging risks | Growth Opportunities | APAC Insurance

Friday, July 18, 2025
Axa china biotech services sign mou to explore cancer treatment option for policyholders rein asia
Axa china biotech services sign mou to explore cancer treatment option for policyholders rein asia

Emerging risks | Growth opportunities | APAC insurance

Friday, 18 July 2025
Linkedin
Newsletter
Free trial
Subscribe
Axa china biotech services sign mou to explore cancer treatment option for policyholders rein asia

Dedicated hubs

Life and Health
LifeandHealth_Menuwebp
Cyber
Cyber_Menuwebp
Energy
EnergyMenuwebp
Marine
MarineMenuwebp
Regulation
RegulationMenuwebp
Capital management
CapitalMenu
Nat cat
NatCatMenu

Browse content

AXA, China Biotech Services sign MoU to explore cancer treatment option for policyholders

Partnership aims to bring together AXA’s insurance expertise and China Biotech Services’ focus on precision diagnostics and therapeutics.
Axa china biotech services sign mou to explore cancer treatment option for policyholders rein asia

Reih Angeles

THIS PREMIUM INSIGHT IS FOR SUBSCRIBERS ONLY.

Stay ahead with precise, independent journalism of APAC's insurance markets.

Unlocked access today:

Already subscribed? Log in using the form below or click here

Share this article

Read next

personal-accident-surges-85-in-indias-gi-market-in-june
_indonesias-takaful-sector-faces-tighter-capital-rules-as-market-share-dips-in-early-2025-fitch
marine-insurers-hike-war-risk-rates-amid-renewed-red-sea-ship-attacks
australias-cyclone-pool-continues-expansion-as-alfred-drives-surge-in-claims
financial-resilience-and-adaptability-to-shield-asias-life-insurers-from-2025-volatility
indias-insurance-market-rises-5-in-june-2025-but-crop-insurers-see-sharp-drop
tariffs-slow-chinas-insurance-growth-asia-market-diverges-swiss-re
zurich-targets-efficiency-to-grow-sme-presence-in-under-served-apac-markets
Malaysias RBC 2 to reshape insurer strategies
midyear-renewals-see-rates-continue-to-soften-across-asia-pacific
Axa china biotech services sign mou to explore cancer treatment option for policyholders rein asia

© Playfair Media 2024

17/F, 80 Gloucester Road, Wan Chai, Hong Kong